## HWM: Howmet Aerospace Inc. - XLI: Industrials

### Executive Summary

VALUE thesis: PEG 0.80 indicates fundamental undervaluation. Quality metrics strong (ROE 30%, ROA 11%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($184.81)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 6, Bearish: 0)

**1. The Aerospace Recovery Is at ‘End of the Beginning.’ 7 Stocks for 2026.**
- Source: Barron's | 20251210T210826 | Somewhat-Bullish | Relevance: 99%
-  Aerospace and Defense stocks have shown strong performance in 2025, with the iShares Aerospace and Defense ETF up about 40% year-to-date. Despite ongoing supply-chain issues, several companies are poised for further growth in 2026 as production stabilizes. The article provides a list of seven stocks expected to benefit from this recovery.

**2. The Aerospace Recovery Is at ‘End of the Beginning.’ 7 Stocks for 2026.**
- Source: Barron's | 20251210T210854 | Somewhat-Bullish | Relevance: 99%
-  Aerospace and defense stocks have performed strongly in 2025, with the iShares Aerospace and Defense ETF up 40% year-to-date. This growth occurred despite ongoing supply chain issues within the sector. The article suggests that several companies are well-positioned to benefit from a return to normal production levels in 2026.

**3. The Aerospace Recovery Is at ‘End of the Beginning.’ 7 Stocks for 2026.**
- Source: Barron's | 20251211T090809 | Somewhat-Bullish | Relevance: 99%
-  Aerospace and Defense stocks have seen significant gains in 2025, with the iShares Aerospace and Defense ETF up approximately 40%. Despite ongoing supply-chain issues, several companies in the sector are poised for further benefits as production normalizes in 2026. This article identifies seven specific stocks that are expected to perform well in the aerospace recovery through 2026.

**4. The Aerospace Recovery Is at ‘End of the Beginning.’ 7 Stocks for 2026.**
- Source: Barron's | 20251210T210755 | Bullish | Relevance: 99%
-  Aerospace and defense stocks have performed strongly in 2025, even with ongoing supply-chain issues. The iShares Aerospace and Defense ETF has seen a significant 40% increase year-to-date. The article suggests that several stocks are poised for further benefits as production normalizes in 2026.

**5. The Aerospace Recovery Is at ‘End of the Beginning.’ 7 Stocks for 2026.**
- Source: Barron's | 20251210T210825 | Bullish | Relevance: 98%
-  Aerospace and defense stocks have performed strongly in 2025, despite ongoing supply-chain issues. The article predicts that several stocks are set to benefit significantly as aerospace production normalizes in 2026. It suggests that the industry is moving past the initial recovery phase and into a more stable growth period.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-14 | B of A Securiti | $250 | $215 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-14 | B of A Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 3 ($0.07M) |
| Sells | 1 ($0.12M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 58.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- JPMORGAN CHASE & CO: 14.3% (+80.7%)
- Vanguard Group Inc: 12.2% (+1.4%)
- Blackrock Inc.: 12.0% (+4.5%)
- State Street Corpora: 4.5% (+1.6%)
- FMR, LLC: 4.0% (+2.4%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.80 indicates undervaluation relative to growth. Forward P/E 44.2x stretched relative to 20% growth. Quality metrics strong (ROE 30%, ROA 11%, margin 18%). Balance sheet: strong liquidity (2.4x). Analyst sentiment positive (1 raises, avg +16%). Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $78.8B |
| Beta | 1.32 |
| 52W Range | $105.04 - $211.95 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.80 |
| Forward P/E | 44.2 |
| Current P/E | 53.0 |
| YoY Growth | 20.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -7.2% to -3.4% (+3.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 7.4pp (needs >4.0% for momentum thesis). MRS_5 turning positive (1.6%) - potential reversal signal. Underperforming sector by 4.6pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.14x) but short-term weakness (below SMA20). MACD histogram bearish (-0.92), momentum weakening. RSI neutral at 47.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.37% (CS: 20) | Weak |
| RSI_14 | 47.2 | Neutral |
| MACD Histogram | -0.92 | Bearish |
| vs SMA20 | 0.988x | Below |
| vs SMA50 | 0.990x | Below |
| vs SMA200 | 1.143x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $195.89
- **Stop Loss:** $184.81 (5.7% risk)
- **Target:** $218.05 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 124
- **Position Value:** $24,290.36
- **Portfolio %:** 24.29%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-12 (Est: $0.96)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.91 | $0.95 | +4.5% |
| 2025Q2 | $0.87 | $0.91 | +4.2% |
| 2025Q1 | $0.78 | $0.86 | +10.7% |
| 2024Q4 | $0.72 | $0.74 | +2.8% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*